The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and ...
PharmaEssentia Accelerates Global Expansion with US and Japan Drug Approvals and US$46 Million Manufacturing Investment ...
Median 234 days from first CRO contact to site activation, range 74 to 657; median ethics approval 48 days, median governance ...
Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, announced the acquisition of Energon ...
NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
Proprietary BRiSC™ platform to advance the discovery and development of next-generation dual-targeting siRNA medicines.
Rona Therapeutics announced it has granted Roche an exclusive worldwide license for Rona's investigational RNAi candidate ...
IVI Institute, the global leader in fertility care, announced that The World Egg and Sperm Bank (TWESB), a trusted provider ...
Funding Will Accelerate Development of a Nanofluidic Antiretroviral Implant Designed to Deliver Continuous HIV Protection for ...
NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results